We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Over Met Doc

Artsen om laboratoriumresultaten overal efficiënt en effectief goed te keuren

1. Eases the workload and reduces the time Pathologists spend in the lab.

2. Finger print Authentication available for logging in the app.

3. Allows Doctors to access Patient information and approve the results on the go and reduces TAT allowing labs to handle more Patients load.

4. Reference Range, Device Value, QC Value will be differentiated and shown.

5. Allows Doctors to view Past Patient records for better understanding of Patient’s ailments.

6. Reduces Patient wait time substantially for timely treatment.

7. Dashboard helps Patient search for easy viewing and approving specific tests.

8. Dashboard lists Tasks containing Pending approval, Delayed results, Critical results, STAT Approval, Co-Authorization.

9. Option of Quick Approval, where all the Patients reports will be listed in PDF format and can be approved viewing Patient by Patient continuously.

10. Option to download the report in app is available.

Wat is er nieuw in de nieuwste versie 8.0

Last updated on Oct 14, 2022

To approve reports from remote locations any time anywhere. Avoids delay of reporting, improvises turn around time and makes further management of patients quicker and more effective.

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van Met Doc 8.0

Geüpload door

Luka Sarthania

Android vereist

Android 5.0+

Meer Info

Met Doc Screenshots

Talen
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.